ClawTerminal Blog
Markets data for AI agents — and how to use it.
Two threads. First, how to wire your agent (Claude, ChatGPT, Cursor) to a live markets database over MCP. Then, the research playbooks that data unlocks — insider buying, congressional trades, fund flows, biotech catalysts, value screens — with the academic edge and the anti-noise filters that separate signal from artifact.
Connect your agent
Wire Claude, ChatGPT, Cursor or a custom agent to real markets data.
How to give Claude access to SEC filings (free MCP server)
EDGAR is a maze of HTML and XBRL. Point Claude at one MCP endpoint and ask for 8-Ks, insider trades and fundamentals in plain English instead.
8 min read ConnectThe best MCP server for stock-market data
What to look for in a markets MCP server — coverage, freshness, auth, tool design — and how ClawTerminal’s 160+ tools compare.
9 min read ConnectHow to connect ChatGPT to live markets data
ChatGPT Developer Mode and custom connectors can call MCP tools. Here is how to give ChatGPT SEC filings, prices and macro — no plugins.
7 min read ConnectHow to build an AI investing analyst
An agent is a model plus tools plus a loop. Keep the model, add a markets database over MCP, and let it run a full research workflow on its own.
10 min readResearch playbooks
What the data is actually for — with the documented edge and the filters.
How to find insider buying that actually predicts returns
Not all Form 4 buys are signal. The edge lives in opportunistic, operating-insider cluster buys in small-caps — and the filters that drop the noise.
11 min read PlaybookHow to track congressional stock trades (STOCK Act)
The average member does not beat the index. Leadership and committee-power members are a different story. How to read STOCK Act disclosures honestly.
9 min read Playbook13F whale-watching: how to read institutional holdings
13F is 45 days stale and longs-only. The alpha is not the whole book — it is the manager’s concentrated best ideas. How to find them.
10 min read PlaybookFDA catalysts: how drug approvals move biotech stocks
The run-up often matters more than the print. How to track approvals and recalls, run an event study, and avoid the “sell the news” trap.
9 min read PlaybookThe Magic Formula screen, automated
Greenblatt ranked cheap (high earnings yield) and good (high ROIC). Build the screen in one query — and understand the multi-year discipline tax.
10 min read PlaybookReading the macro regime: growth × inflation quadrants
Most asset moves are regime-driven. Classify the growth-and-inflation quadrant, watch liquidity, and apply the 200-day filter before stock-picking.
10 min read PlaybookHow to evaluate your portfolio (beyond the return)
Your return tells you almost nothing alone. We ran two real portfolios through the analytics — Sharpe, drawdown, beta, concentration, risk contribution — and the high-return one was no better than the index.
11 min readIn the data
We run the viral charts and the day’s headlines through the terminal and check them against the filings.
Michael Burry’s Apollo chart, fact-checked
His viral chart says your retirement quietly funds Elon’s AI. We traced the annuity-to-GPU chain through the filings — mostly true, with the scary numbers turned up to eleven.
9 min read Autonomous runAn autonomous agent’s overnight research run
We pointed OpenClaw at the terminal and let it run: sweep the day, grade a viral chart against the filings, value the megacaps. What hands-off markets research actually looks like.
9 min read Field guideExotic ETFs: the weird and wonderful
An ETF for space (ticker UFO), for K-pop’s labels, one literally called Animal Spirits with 2x leverage. The strangest real funds — and how to spot a fee trap.
10 min readCompany spotlights
A big name, the real filings, and whether it’s cheap or expensive — with charts.
Is Nvidia stock cheap or expensive?
45x earnings but a 0.7 PEG. We pulled the filings and the price — revenue up 20x in six years, a 1.8% FCF yield — and charted what you’re paying at every multiple.
10 min read SpotlightIs Alphabet (Google) cheap or expensive?
The “cheap Mag7” already re-rated. At 33x with 15% growth and a $91B AI capex bill eating the cash flow, is the bargain gone? The filings, charted.
9 min read SpotlightIs Apple stock cheap or expensive?
42x earnings near an all-time high — on ~6% revenue growth. The cleanest case of paying a growth multiple for a low-growth, buyback-powered cash machine.
9 min read SpotlightIs Tesla stock cheap or expensive?
~390x earnings on a shrinking profit base. Tesla breaks the multiple entirely — so we reverse it: what would earnings have to become to justify the price?
9 min readPoint your agent at the data
One MCP endpoint, 160+ markets-research tools, a free closed-beta key. Connect Claude, ChatGPT, Cursor or any MCP-capable agent in under a minute.